Clinical Trial Update: Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing niraparib alone to niraparib plus bevacizumab in advanced ovarian, fallopian tube, and peritoneal cancers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Zejula (Niraparib)

Snippet

Sponsor: AGO Study Group | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | Status: RECRUITING